<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="143040">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02060084</url>
  </required_header>
  <id_info>
    <org_study_id>SYSD2012021</org_study_id>
    <nct_id>NCT02060084</nct_id>
  </id_info>
  <brief_title>Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm</brief_title>
  <official_title>Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wang Hua</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kunshan First People's Hospital  Affiliated to Jiangsu University</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gut of newborn preterm is sterile,  immediately by the mother and the surrounding
      environment from microbial colonization. As the effects of diet, intestinal flora is rapidly
      changed. Preterm children significantly delay in the establishment of normal flora,during
      hospitalization because of no breastfeeding, use of antibiotics, enteral feeding delay,
      combat disease and other factors. In this study, hospitalized preterm children for the
      study, the  prospective randomized double-blind controlled study, to find oral intestinal
      bifidobacteria and lactobacilli and bifidobacteria subspecies composition and distribution,
      and further show intestinal bacteria in premature children case group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preterm infants are at high risk of deeding intolerance especially low birth weight infants,
      Whether oral triple viable Bifidobacterium and early Micro-feeding may improve the symptoms
      of feeding intolerance.

      84 preterm infants BW(birth weight) less than 2.5kg,entered neonatal intensive care
      unit(NICU) less than 24 hours and meet the Inclusion Criteria of this study will be Randomly
      divided into three groups, control group、 treatment group1 (Triple viable Bifidobacterium
      0.5g bid po)、treatment group2 （Triple viable Bifidobacterium 0.5g bid po and early
      micro-feeding）. treatment period for more than 1 week. For three groups, feeding
      symptoms,the traits and frequency of stool of 3 days,1 weeks,2 weeks.And the stool flora
      measured by PCR.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Intestinal flora</measure>
    <time_frame>up to one week</time_frame>
    <safety_issue>No</safety_issue>
    <description>measure the intestinal flora of three groups and identify the effect of early oral triple viable bifidobacterium  for preterm infants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feeding intolerance</measure>
    <time_frame>up to one week</time_frame>
    <safety_issue>No</safety_issue>
    <description>compare the feeding intolerance rate of three groups</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Disorder of Stomach Function and Feeding Problems in Newborn</condition>
  <condition>Feeding and Eating Disorders of Childhood</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>warm water 3ml po</description>
  </arm_group>
  <arm_group>
    <arm_group_label>treatment group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Triple viable Bifidobacterium 0.5 bid po</description>
  </arm_group>
  <arm_group>
    <arm_group_label>treatment group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Triple viable Bifidobacterium  0.5 bid po and early Micro-feeding</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triple viable Bifidobacterium 0.5 bid po</intervention_name>
    <arm_group_label>treatment group 1</arm_group_label>
    <arm_group_label>treatment group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>early Micro-feeding</intervention_name>
    <arm_group_label>treatment group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm with birth weight &lt;2.5kg

        Exclusion Criteria:

          -  Gastrointestinal bleeding and NEC,Kidney,liver function abnormal and have Serious
             congenital malformation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Linxia Qiao, MD</last_name>
    <phone>15995687569</phone>
    <email>mumeer@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kunshan First Hospital</name>
      <address>
        <city>Kunshan</city>
        <state>Jiangsu</state>
        <zip>215300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linxia Qiao, MD</last_name>
      <phone>+8615995687569</phone>
      <email>mumeer@126.com</email>
    </contact>
    <investigator>
      <last_name>Linxia Qiao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>February 9, 2014</lastchanged_date>
  <firstreceived_date>February 2, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Kunshan First People's Hospital  Affiliated to Jiangsu University</investigator_affiliation>
    <investigator_full_name>Wang Hua</investigator_full_name>
    <investigator_title>Director of pediatric</investigator_title>
  </responsible_party>
  <keyword>preterm;</keyword>
  <keyword>Intestinal flora;</keyword>
  <keyword>early Micro-feeding</keyword>
  <keyword>Feeding intolerance</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Eating Disorders</mesh_term>
    <mesh_term>Stomach Diseases</mesh_term>
    <mesh_term>Feeding and Eating Disorders of Childhood</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
